Skip to content
Alpha Edge Investing

Alpha Edge Investing

"Investors operate with limited funds and limited intelligence, they don’t need to know everything. As long as they understand better than others, they have an edge.” – George Soros

  • Home
  • Earnings Updates/ Corporate Actions
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trust/ ETF
  • News
  • My Opinions/ Views
  • Others
  • About Me
  • Contact
  • Disclaimer
  • Community and Support Forums
  • Toggle search form

DBS: Ascendas REIT – Buy Target Price $3.65

Posted on August 9, 2022August 9, 2022 By alanyeo No Comments on DBS: Ascendas REIT – Buy Target Price $3.65

News Analysis: Back to acquiring well-located industrial properties with attractive fundamentals

Back to acquiring well-located industrial properties with attractive fundamentals

  • Proposed acquisition of Philips APAC Centre for S$104.8m
  • Acquisition likely to be debt-funded, generating a DPU accretion of c.029%
  • In line with AREIT’s focus to grow its exposure in the digital economy and biomedical/lifesciences sectors
  • Such opportunistic deals to drive further earnings growth albeit the small quantum (compared to AREIT’s AUM of S$17bn)

Source: Philips – Singapore

Proposed acquisition of Philips APAC Center for S$104.8m

  • Centrally located at 622 Lorong 1 Toa Payoh
  • Purchase consideration of S$104.8m
    • c.6.0% discount to valuation of S$111.5m
  • High occupancy of 95.7% with WALE of 4.5 years
  • Initial NPI yield of 7.2% (6.8% post-cost)
    • c.0.29% accretion to DPU
    • Gearing to inch up slightly from 36.7% to c.37.1%
  • Remaining land tenure of c.21 years

Philips’ APAC headquarters and innovation centre

  • Sale and leaseback with Philips Electronics
    • Philips occupies more than two-thirds of the property
    • Total of 4 tenants in the property
  • Six-storey building which comprises laboratory, R&D, warehouse and ancillary office space
  • GFA of 37,975 sqm

Our thoughts

This acquisition came as a positive surprise for AREIT and is aligned with their strategic focus to grow its digital economy, and biomedical and lifesciences exposure. Although the S$104.8m acquisition is small compared to its AUM of c.S$17bn, the accretion to DPU is a relatively healthy c.0.29%. We believe the acquisition will be funded by debt, and AREIT’s gearing will inch up slightly from 36.7% to c.37.1%, leaving them with ample debt headroom.

The initial NPI yield of c.6.8% (post-costs) is also relatively attractive although the remaining land tenure of the property is only c.21 years. We believe the central location of the property will continue to appeal to tenants and the anchor tenant, Philips Electronics, has only recently redeveloped the property in 2016 to transform it into its regional headquarters. In line with AREIT’s guidance that it will continue to be on the lookout for smaller acquisitions as portfolio deals are increasingly expensive, its healthy gearing will support fully debt-funded acquisitions and generate DPU accretion.

We remain optimistic on AREIT as the c.S$466m of ongoing projects is continue to drive earnings growth in the coming two years, while acquisitions of well-located industrial properties like this will generate DPU accretion going forward. We will be maintaining our BUY recommendation with a TP of S$3.65.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
Research - Equities Tags:Ascendas REIT

Post navigation

Previous Post: DBS: Ascott Residence Trust – Buy Target price $1.40
Next Post: DBS: CSE Global Ltd – Buy Target Price $0.59

Related Posts

Maybank: CapitaLand Ascendas REIT – Buy Target Price $3.50 Research - Equities
UOBKH: REITs – Singapore (Overweight) Research - Equities
CIMB: Ascendas REIT – Add Target Price $3.21 Research - Equities
DBS: Ascendas REIT – Buy Target Price $3.65 Research - Equities
UOBKH: REITs – Singapore (Overweight) Research - Equities
DBS: Ascendas REIT – Buy Target Price $3.65 Research - Equities
UOBKH: Ascendas REIT – Buy Target Price $3.45 (Previous $3.69) Research - Equities
CIMB: Ascendas REIT – Add Target Price $3.20 Research - Equities
KGI: Ascendas REIT (AREIT SP) – 1H22 results to see positive rental reversions and inorganic growth Research - Equities
Downward spiral looms for 3QFY2022 – PhillipCapital Research - Equities
Edge: AREIT’s income to increase from new management agreements and assets acquired in the US: RHB Research - Equities
KE: Invest ASEAN SG 2022 – Navigating growth & inflation Research - Equities

Leave a Reply

You must be logged in to post a comment.

Login

Log In
Register Lost Password
Get new posts by email
Chat on WhatsApp
  • Earnings Updates/ Corporate Actions
  • My Opinions/ Views
  • News
  • Others
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trusts/ ETF

Copyright © 2023 Alpha Edge Investing.

Powered by PressBook Grid Blogs theme